Quality of life in brain metastases radiation trials: A literature review

Current Oncology

Volumn 15, Issue 5, 2008, Pages 25-45

  Wong, J ^a   Hird, A ^a   Kirou Mauro, A ^a   Napolskikh, J ^a   Chow, Edward ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Brain metastasis; Quality of life; Whole brain radio therapy

Indexed keywords

BROXURIDINE; CARBOPLATIN; CHLOROETHYLNITROSOUREA; EFAPROXIRAL; LONIDAMINE; METRONIDAZOLE; NAVELBINE; PENTOXIFYLLINE; RAZOXANE; TEGAFUR; TEMOZOLOMIDE; TENIPOSIDE; TOPOTECAN;

BARTHEL INDEX; BRAIN FUNCTION; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COGNITION; HUMAN; KARNOFSKY PERFORMANCE STATUS; MULTIPLE CANCER; OUTCOMES RESEARCH; OVERALL SURVIVAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; RECURRENT CANCER; REVIEW; SURVIVAL TIME; WHOLE BODY RADIATION;

EID: 68649104529     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v15i5.290     Document Type: Review

References (83)

1. Loeffler JS, Patchell RA, Sawaya R. Treatment of metastatic cancer. In: Devita VT, Hellman S, Rosenburg SA, eds. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven Publishers; 1997: 2523-2536.
2. Cairncross JG, Kim JH, Posner JB. Radiation therapy for brain metastases. Ann Neurol 1980;7:529-41.
3. Hoegler D. Radiotherapy for palliation of symptoms in incurable cancer. Curr Probl Cancer 1997;21:129-83.
4. Posner JB. Management of central nervous system metastasis. Semin Oncol 1977;4:81-91.
5. Lohr F, Pirzkall A, Hof H, Fleckenstein K, Debus J. Adjuvant treatment of brain metastases. Semin Surg Oncol 2001;20:50-6.
6. Murray KJ, Scott C, Greenberg HM, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997;39:571-4.
7. Robinet G, Thomas P, Breton JL, et al. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe francais de pneumo-cancerologie (GFPC) protocol 95-1. Ann Oncol 2001;12:59-67.
8. Postmus PE, HaaxmaReiche H, Smit EF, et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy - a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 2000;18:3400-8.
9. DeAngelis LM, Currie VE, Kim JH, et al. The combined use of radiation therapy and lonidamine in the treatment of brain metastases. J Neurooncol 1989;7:241-7.
10. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6:1-9.
11. Tsao MN, Lloyd NS, Wong RK, et al. Radiotherapeutic management of brain metastases: a systematic review and metaanalysis. Cancer Treat Rev 2005;31:256-73.
12. World Health Organization. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference; New York, NY, U.S.A.; June 19-22, 1946. Signed on July 22, 1946 (Official Records of the World Health Organization, no. 2, p. 100). Entered into force on April 7, 1948. [Available online at: http://www.who.int/about/definition/en/print.html; cited September 10, 2008]
13. Yancik R, Edwards BK, Yates JW. Assessing the quality of life of cancer patients: practical issues in study implementation. J Psychosoc Oncol 1989;7:59-74.
14. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 1996;14:671-9.
15. Tannock IF. Treating the patient, not just the cancer. N Engl J Med 1987;317:1534-5.
16. Bezjak A, Adam J, Panzarella T, et al. Radiotherapy for brain metastases: defining palliative response. Radiother Oncol 2001;61:71-6.
17. Chow E, Davis L, Holden L, Tsao M, Danjoux C. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage 2005;30:18-23.
18. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-72.
19. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-9.
20. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427-34.
21. Phillips TL, Scott CB, Leibel SA, Rotman M, Weigensberg IJ. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: Report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 1995;33:339-48.
22. Harwood AR, Simson WJ. Radiation therapy of cerebral metastases: a randomized prospective clinical trial. Int J Radiat Oncol Biol Phys 1977;2:1091-4.
23. Noordijk EM, Vecht CJ, HaaxmaReiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994;29:711-17.
24. Eyre HJ, Ohlsen JD, Frank J, et al. Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. J Neurooncol 1984;2:325-30.
25. Rhomberg W, Eiter H, Boehler F, Saely C, Strohal R. Combined razoxane and radiotherapy for melanoma brain metastases. A retrospective analysis. J Neurooncol 2005;74:295-9.
26. Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C. Observer error in grading performance status in cancer patients. Support Care Cancer 1999;7:332-5.
27. Murray KJ, Scott C, Zachariah B, et al. Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04. Int J Radiat Oncol Biol Phys 2000;48:59-64.
28. Haie-Meder C, Pellae-Cosset B, Laplanche A, et al. Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother Oncol 1993;26:111-16.
29. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996;78:1470-6.
30. Buchanan DR, O'Mara AM, Kelaghan JW, Minasian LM. Quality-of-life assessment in the symptom management trials of the national cancer institute-supported community clinical oncology program. J Clin Oncol 2005;23:591-8.
31. Conill C, Verger E, Salamero M. Performance status assessment in cancer patients. Cancer 1990;65:1864-6.
32. Grieco A, Long CJ. Investigation of the Karnofsky performance status as a measure of quality of life. Health Psychol 1984;3:129-42.
33. Ochs J, Mulhern R, Kun L. Quality of life assessment in cancer patients. Am J Clin Oncol 1988;11:415-21.
34. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
35. Epstein BE, Scott CB, Sause WT, et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28. Cancer 1993;71:1362-7.
36. Auchter RM, Lamond JP, Alexander E, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996;35:27-35. [See comment]
37. Jyothirmayi R, Saran FH, Jalali R, et al. Stereotactic radiotherapy for solitary brain metastases. Clin Oncol (R Coll Radiol) 2001;13:228-34.
38. Li B, Yu J, Suntharalingam M, et al. Comparison of three treatment options for single brain metastasis from lung cancer. Int J Cancer 2000;90:37-45.
39. Roos DE, Wirth A, Burmeister BH, et al. Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiother Oncol 2006;80:318-22.
40. Horton J, Baxter DH, Olson KB. The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med 1971;111:334-6.
41. Wolfson AH, Snodgrass SM, Schwade JG, et al. The role of steroids in the management of metastatic carcinoma to the brain. A pilot prospective trial. Am J Clin Oncol 1994;17:234-8.
42. Chang DB, Yang PC, Luh KT, Kuo SH, Hong RL, Lee LN. Late survival of non-small cell lung cancer patients with brain metastases. Influence of treatment. Chest 1992;101:1293-7.
43. Routh A, Khansur T, Hickman BT, Bass D. Management of brain metastases: past, present, and future. South Med J 1994;87:1218-26.
44. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981; 7:1633-8.
45. Chatani M, Matayoshi Y, Masaki N, Inoue T. Radiation therapy for brain metastases from lung carcinoma: the second prospective randomized trial [Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 1994;54:1380-7.
46. Gelber RD, Larson M, Borgelt BB, Kramer S. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 1981;48:1749-53.
47. Nieder C, Nestle U, Niewald M, Schnabel K. Accelerated radiotherapy for brain metastases. Radiother Oncol 1997;45:17-22.
48. Portaluri M, Bambace S, Giuliano G, et al. Fractionations in radiotherapy of brain metastases. Tumori 2004;90:80-5.
49. Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol) 1996;8:308-15.
50. Kurtz JM, Gelber R, Brady LW, Carella RJ, Cooper JS. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981;7:891-5.
51. Bach F, Sorensen JB, Adrian L, et al. Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regiments of therapeutic brain irradiation. Lung Cancer 1996;15:171-81.
52. Johnson FE, Harrison BR, McKirgan LW, Raju PI, Roy TK, Virgo KS. A phase II evaluation of pentoxifylline combined with radiation in the treatment of brain metastases. Int J Oncol 1998;13:801-5.
53. Kocher M, Eich HT, Semrau R, Güner SA, Müller RP. Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases. Strahlenther Onkol 2005;181:20-5.
54. Stea B, Suh JH, Boyd AP, Cagnoni PJ, Shaw E on behalf of the REACH Study Group. Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: determinants of response and its prognostic value for subsequent survival. Int J Radiat Oncol Biol Phys 2006;64:1023-30.
55. Addeo R, Caraglia M, Faiola V, et al. Concomitant treatment of brain metastasis with whole brain radiotherapy and temozolomide (TMZ) is active and improves quality of life. BMC Cancer 2007;7:18.
56. Antonadou D, Coliarakis N, Paraskevaidis M, et al. Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. A phase III study abstract. Int J Radiat Oncol Biol Phys 2002;54:93-4.
57. Guerrieri M, Wong K, Ryan G, Millward M, Quong G, Ball DL. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. Lung Cancer 2004;46:107-11.
58. Hidalgo V, Dy C, Fernandez Hidalgo O, Calvo FA. Simultaneous radiotherapy and cis-platinum for the treatment of brain metastases. A pilot study. Am J Clin Oncol 1987;10:205-9.
59. Verger E, Gil M, Yaya R, et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 2005;61:185-91.
60. Ushio Y, Arita N, Hayakawa T, et al. Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. Neurosurgery 1991;28:201-5.
61. Hazuka MB, Kinzie JJ. Brain metastases: results and effects of re-irradiation. Int J Radiat Oncol Biol Phys 1988;15:433-7.
62. Kurup P, Reddy S, Hendrickson FR. Results of re-irradiation for cerebral metastases. Cancer 1980;46:2587-9.
63. Rosenman J, Choi NC. Improved quality of life of patients with small-cell carcinoma of the lung by elective irradiation of the brain. Int J Radiat Oncol Biol Phys 1982;8:1041-3.
64. Shehata WM, Hendrikson FR, Hindo WA. Radiofractionation technique and retreatment of cerebral metastases of irradiation. Cancer 1974;34:257-61.
65. Abdel-Wahab M, Wolfson A, Raub W, et al. The role of hyperfractionated re-irradiation in metastatic brain disease: a single institutional trial. Am J Clin Oncol 1997;20:158-60.
66. Jawahar A, Ampil F, Wielbaecher C, Hartman GH, Zhang JH, Nanda A. Management strategies for patients with brain metastases: has radiosurgery made a difference? South Med J 2004;97:254-8.
67. Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 1998;16:3563-9.
68. Kondziolka D, Niranjan A, Flickinger JC, et al. Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications. Am J Clin Oncol 2005; 28:173-9.
69. Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 1999;43:549-58.
70. Scott C, Suh J, Stea B, Nabid A, Hackman J. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus wholebrain radiation therapy for brain metastases. Am J Clin Oncol 2007;30:580-7.
71. Bezjak A, Adam J, Barton R, et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002;38:487-96.
72. Gerrard GE, Prestwich RJ, Edwards A, et al. Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol (R Coll Radiol) 2003;15:422-8.
73. Lock M, Chow E, Pond GR, et al. Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy? Clin Oncol (R Coll Radiol) 2004; 16:332-8.
74. Sehlen S, Lenk M, Hollenhorst H, et al. Quality of life (QOL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy. Onkologie 2003;26:38-43.
75. Yaneva MP, Semerdjieva MA. Assessment of the effect of palliative radiotherapy for cancer patients with intracranial metastases using EORTC-QOL-C30 questionnaire. Folia Medica 2006;48:23-9.
76. Li J, Bentzen SM, Renschler M, Mehta MP. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 2007;25:1260-6.
77. Regine WF, Schmitt FA, Scott CB, et al. Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. Int J Radiat Oncol Biol Phys 2004;58:1346-52.
78. Chatani M, Matayoshi Y, Masaki N, Inoue T. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol 1994;170:155-61.
79. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995;75:1151-61.
80. Osoba D, Aaronson NK, Muller M, et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 1996;5:139-50.
81. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 2000;88:2164-71.
82. Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients. A concise QL-index for use by physicians. J Chron Dis 1981;34:585-97.
83. Herman MA, Tremont-Lukats I, Meyers CA, et al. Neurocognitive and functional assessment of patients with brain metastases. Am J Clin Oncol 2003;26:273-9.